|
Tue, 09/09/2025 - 19:53 |
Surgery After EGFR TKI Shows Promise in Prolonging Progression-Free Survival in Metastatic NSCLC |
IASLC |
|
Mon, 06/03/2024 - 13:17 |
Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma |
Fox Chase |
|
Thu, 02/08/2024 - 15:13 |
Lung cancer hijacks immune cell metabolism to fuel its own growth |
Salk Institute |
|
Sun, 08/07/2022 - 10:21 |
Study Finds Second Primary Lung Cancer is 4 Percent and as High as 8 Percent Among Surgery Patients |
IASLC |
|
Fri, 02/11/2022 - 03:51 |
Specific Cancer Driving Protein Plays Important Role in Lung Cancer Development, Moffitt Researchers Say |
Moffitt |
|
Wed, 09/29/2021 - 21:53 |
Most cases of never-smokers lung cancer treatable with mutation-targeting drugs |
Washington Univ... |
|
Tue, 09/21/2021 - 08:53 |
HealthMynes Radiomic Technology Leveraged to Identify Biomarkers That Predict Immunotherapy Treatment Responses |
HealthMyne |
|
Sat, 09/18/2021 - 18:31 |
Enhertu demonstrated robust and durable tumour response of 54.9% in patients with HER2-mutant metastatic non-small cell lung cancer |
AstraZeneca |
|
Tue, 08/31/2021 - 04:59 |
Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients |
HealthMyne |
|
Mon, 06/28/2021 - 06:13 |
Moffitt Receives $10.2 Million Grant to Develop New Lung Cancer Therapies |
Moffitt |
|
Thu, 10/29/2020 - 08:35 |
Lung Cancer Can Strike Anyone |
American Cancer... |
